Delivery Order SPE2DR25D1100-SPE2DR26FCL2C
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,893.18 to AmerisourceBergen Drug Corp for Comirnaty 2025-26 vaccine (12-year and older formulation, 0.3 mL syringes) with a completion date of October 16, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of the company's critical role as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for COMIRNATY 2025-26 vaccine (12 years and older, 0.3mL syringes) with a ceiling value of approximately $20.2K. This competitively awarded, non-set-aside contract was issued on September 29, 2025, with an ultimate completion date of September 30, 2025, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The contract employs firm fixed-price pricing and represents a delivery order...
- The Defense Logistics Agency awarded a $25,242.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Comirnaty 2025-26 vaccine (12 years and up, 0.3ml syringes) with an ultimate completion date of October 15, 2025. This non-set-aside award was issued on September 23, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child order under a larger contract vehicle, this delivery order represents one of many...
- The Defense Logistics Agency awarded a delivery order valued at $1,221.90 to AmerisourceBergen Drug Corp for COMIRNATY 2025-26 vaccine product (12 years and up, 0.3 mL syringes) with an ultimate completion date of November 13, 2025. This is a firm fixed price delivery order with no set-aside designation, awarded competitively on October 22, 2025. The product will be performed and delivered from AmerisourceBergen's Conshohocken, Pennsylvania location. This delivery order is issued under...
- The Defense Logistics Agency awarded a $3,810.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp for COMIRNATY 2024-25 vaccine product (12 years and up, 0.3 mL syringes) with an ultimate completion date of June 3, 2025. This competitively awarded, non-set-aside contract was issued on June 2, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical...
- The Defense Logistics Agency (DLA) awarded a $12,703.00 delivery order to AmerisourceBergen Drug Corp for COMIRNATY 2024-25 vaccine doses (0.3mL syringes for ages 12 and up). This non-set-aside, competitively awarded contract features firm fixed price terms with an ultimate completion date of April 25, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and performs the work at its corporate office location in the same city. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $3,175.75 to AmerisourceBergen Drug Corp for COMIRNATY 2024-25 (12 years and up) vaccine in 0.3 mL syringes, with an ultimate completion date of May 7, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement under DLA's medical supply...
- The Defense Logistics Agency awarded a $10,060.30 firm fixed-price delivery order to AmerisourceBergen Drug Corp for COMIRNATY 2025-26 vaccine (12 years and up, 0.3mL syringes) with an ultimate completion date of November 6, 2025. This is a non-set-aside competitive award issued on October 16, 2025, with performance occurring at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $29,218.80 to AmerisourceBergen Drug Corp for COMIRNATY 2025-26 (12Y UP) vaccine in 0.3mL syringes. The contract was competitively awarded without set-aside designation under firm fixed-price terms, with an ultimate completion date of November 12, 2025. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,460.55 to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Comirnaty 2024-25 vaccine (12 years and up) in 0.3mL syringes. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of June 20, 2025, and performance taking place at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a child order under a larger contract vehicle supporting federal...
- SPE2DR25D1100Indefinite Delivery Contract
- SPE2DR25D1100-SPE2DR26FCL2CDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $38,958.40 to AmerisourceBergen Drug Corp for COMIRNATY 2025-26 vaccine (12 years and up, 0.3ml syringes) with a completion deadline of November 20, 2025. This is a firm fixed-price, non-set-aside competitive award performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order was issued on October 29, 2025, and represents a child contract under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. This award falls under AmerisourceBergen Drug Corp's $999,999,999 Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which extends through December 2026 and serves as a comprehensive global pharmaceutical support vehicle for military healthcare systems. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen supplies vaccines, medications, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The company's consistent receipt of competitively awarded contracts demonstrates its capability to meet federal medical procurement requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $39.0k | 10/29/25 |